Receptors for purines and pyrimidines.
Ralevic
V
V
School of Biomedical Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, England. vera.ralevic@nottingham.ac.uk
Burnstock
G
G
D000818:Animals; D003001:Cloning, Molecular; D006801:Humans; D008024:Ligands; D011687:Purines / Q000378:metabolism*; D011743:Pyrimidines / Q000378:metabolism*; D051381:Rats; D043705:Receptor, Adenosine A2A; D043704:Receptor, Adenosine A2B; D043684:Receptor, Adenosine A3; D018047:Receptors, Purinergic P1 / Q000187:drug effects* / Q000235:genetics; D018048:Receptors, Purinergic P2 / Q000096:biosynthesis / Q000187:drug effects* / Q000235:genetics; D058469:Receptors, Purinergic P2X; D058473:Receptors, Purinergic P2Y2; D015398:Signal Transduction / Q000187:drug effects / Q000235:genetics; D015854:Up-Regulation
D008024:Ligands; C546385:P2RY2 protein, human; D011687:Purines; D011743:Pyrimidines; D043705:Receptor, Adenosine A2A; D043704:Receptor, Adenosine A2B; D043684:Receptor, Adenosine A3; D018047:Receptors, Purinergic P1; D018048:Receptors, Purinergic P2; D058469:Receptors, Purinergic P2X; D058473:Receptors, Purinergic P2Y2